Hostname: page-component-848d4c4894-2xdlg Total loading time: 0 Render date: 2024-06-27T16:39:22.809Z Has data issue: false hasContentIssue false
  • English
  • Français

Dietary restriction of energy and sugar results in a reduction in human cytochrome P450 2E1 activity

Published online by Cambridge University Press:  09 March 2007

Isabelle Leclercq ,
Yves Horsmans ,
Jean-Pierre Desager ,
Stanislas Pauwels  and
André P. Geubel
Isabelle Leclercq
Affiliation:
Gastroenterology Unit, Université Catholique de Louvain, Brussels, Belgium
Yves Horsmans*
Affiliation:
Gastroenterology Unit, Université Catholique de Louvain, Brussels, Belgium
Jean-Pierre Desager
Affiliation:
Gastroenterology Unit, Université Catholique de Louvain, Brussels, Belgium
Stanislas Pauwels
Affiliation:
Gastroenterology Unit, Université Catholique de Louvain, Brussels, Belgium
André P. Geubel
Affiliation:
Gastroenterology Unit, Université Catholique de Louvain, Brussels, Belgium
*
*Corresponding author: Dr Y. Horsmans, fax +32 2764 8272, email Horsmans@gaen.ucl.ac.be
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Dietary habits are often considered as a pathogenic factor for fatty liver. The impact of dietary intake and steatosis on drug metabolism remains poorly investigated. Our aim was to assess the effect of dietary intake on in vivo cytochrome P450 (CYP) activities in eleven patients with abnormal liver function tests potentially due to fatty liver and associated with a high-sugar diet. Liver function tests, liver volume, aminopyrine breath test (ABT) and chlorzoxazone (CZ) pharmacokinetics (area under the curve, AUC) which are known to reflect CYP2E1 activity were evaluated before and after 2 months restriction of dietary sugar intake. Features at inclusion were an increased BMI (30·3 (sd 3·2) kg/m2), high hepatic volume (1·96 (sd 0·48) litres), hyperechogenic liver parenchyma, elevated liver enzyme activities (alanine aminotransferase (EC 2.6.1.2) 58·6 (sd 17·4) IU/l with alanine aminotransferase : aspartate aminotransferase (EC 2.6.1.1) ratio > 1), together with a normal ABT value (0·68 (sd 0·21) % specific activity of administered dose of [14C]aminopyrine in breath after 1 h) and a high CYP2E1 activity (CZ AUC 20·3 (sd 7·1) μg/ml per h). A dietary sugar restriction was prescribed. On the basis of repeated interviews by the same dietitian, unaware of any clinical and biochemical data, six patients remained compliant to the diet and exhibited reductions in BMI (P < 0·001), serum alanine aminotransferase (P = 0·008), liver volume (P = 0·002) and CYP2E1 activity (P = 0·007), a significant increase in ABT (P < 0·001) together with the disappearance of liver hyperechogenicity at ultrasound. In contrast, the five non-compliant patients did not show any significant change in any of these variables. In conclusion, CYP2E1 activity is induced in patients with perturbations of liver function tests potentially due to fatty liver. In these patients, effective dietary sugar restriction is associated with a reduction in liver volume, a reduction in CYP2E1 activity and an increased aminopyrine metabolism rate.

Keywords

Cytochrome P450AminopyrineChlorzoxazoneLiver
Type
Research Article
Information
British Journal of Nutrition , Volume 82 , Issue 4 , October 1999 , pp. 257 - 262
Copyright
Copyright © The Nutrition Society 1999

References

Aarsland, A, Chinkes, D & Wolf, RR (1997) Hepatic and whole-body fat synthesis in humans during carbohydrate overfeeding. American Journal of Clinical Nutrition 65, 1774–1782.CrossRefGoogle ScholarPubMed
Abdel-Razzak, Z, Loyer, P, Fautrel, A, Gautier, JC, Corcos, L, Turlin, B & Guillouzo, A (1993) Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary cultures. Molecular Pharmacology 44, 707–715.Google Scholar
Acheson, KJ, Schutz, Y, Bessard, T, Ravussin, E, Jequier, E & Flatt, JP (1984) Nutritional influences on lipogenesis and thermogenesis after a carbohydrate meal. American Journal of Physiology 246, E62–E70.Google ScholarPubMed
Adam, R, Reynes, M, Johann, M, Morino, M, Astarcioglu, I, Kafetzis, I, Castaing, D & Bismuth, H (1991) The outcome of steatotic grafts in liver transplantation. Transplantation Proceedings 23, 1538–1540.Google ScholarPubMed
Alpers, DH, Sabesin, SM & White, HM (1993) Fatty liver: biochemical and clinical aspects. In Diseases of the Liver, 7th ed., pp. 825–871 [Schiff, L and Schiff, ER, editors]. Philadelphia, PA: JB Lippincott Company.Google Scholar
Barnett, CR, Flatt, PR & Ioannides, C (1988) Role of ketone bodies in the diabetes-induced changes in hepatic mixed-function oxidase activities. Biochimica et Biophysica Acta 967, 250–254.CrossRefGoogle ScholarPubMed
Black, M (1984) Acetaminophen hepatotoxicity. Annual Review of Medicine 35, 577–593.CrossRefGoogle ScholarPubMed
Burt, AD, MacSween, RNM, Peters, TJ & Simpson, KJ (1991) Non-alcoholic fatty liver: causes and complications. In Oxford Textbook of Clinical Hepatology, pp. 865–871 [McIntyre, N, Benhamou, JP, Bircher, J, Rizetto, M and Rodes, J, editors]. Oxford: Oxford University Press.Google Scholar
Cousins, MJ, Plummer, JL & Hall, PM (1989) Risk factors for halothane hepatitis. Australian New Zealand Journal of Surgery 59, 5–14.CrossRefGoogle ScholarPubMed
Day, CP & Yeaman, SJ (1994) The biochemistry of alcohol-induced fatty liver. Biochimica et Biophysica Acta 1215, 33–48.CrossRefGoogle ScholarPubMed
Eriksson, S, Eriksson, KF & Bondesson, L (1986) Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Medica Scandinavica 220, 83–88.CrossRefGoogle ScholarPubMed
Fiatarone, JR, Coverdale, SA, Batey, RG & Farrell, GC (1991) Non-alcoholic steatohepatitis: impaired antipyrine metabolism and hypertriglyceridaemia may be clues to its pathogenesis. Journal of Gastroenterology and Hepatology 6, 585–590.CrossRefGoogle ScholarPubMed
Frayn, K & Kingman, S (1995) Dietary sugars and lipid metabolism in humans. American Journal of Clinical Nutrition 62, Suppl., 250S–263S.CrossRefGoogle ScholarPubMed
Girre, C, Lucas, D, Hispard, E, Menez, C, Dally, S & Menez, JF (1994) Assessment of cytochrome P450 2E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. iochemical Pharmacology 47, 1503–1508.Google ScholarPubMed
Horsmans, Y, De Konninck, X, Geubel, A & Pauwels, S (1995 a) Microsomal function in hepatitis B surface antigen healthy carriers: assessment of cytochrome P-450 1A2 activity by the 14C-caffeine breath test. Pharmacology Toxicology 77, 247–249.CrossRefGoogle ScholarPubMed
Horsmans, Y, Geubel, AP & Pauwels, S (1995 b) Reliability of aminopyrine breath test using a single breath collection. Digestive Diseases and Sciences 40, 1581.CrossRefGoogle ScholarPubMed
Keeffe, EB, Adesman, PW, Stenzel, P & Palmer, RM (1987) Steatosis and cirrhosis in an obese diabetic. Resolution of fatty liver by fasting. Digestive Diseases and Sciences 32, 441–445.CrossRefGoogle Scholar
Kharasch, E Hankins D, Mautz, D & Thummel, KE (1996) Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis. Lancet 347, 1367–1371.CrossRefGoogle ScholarPubMed
Krishnaswamy, K, Kalamegham, R & Naidu, NA (1984) Dietary influences on the kinetics of antipyrine and aminopyrine in human subjects. British Journal of Clinical Pharmacology 17, 139–146.CrossRefGoogle ScholarPubMed
Kuwahara, M & Hachimura, K (1980) Image enhancement and left ventricular contour extraction techniques applied to radioisotope angiocardiograms. Automedica 3, 107–119.Google Scholar
Leclercq, I, Desager, JP & Horsmans, Y (1998 a) Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single-dose watercress ingestion. Clinical Pharmacology and Therapeutics 64, 144–149.CrossRefGoogle Scholar
Leclercq, I, Horsmans, Y & Desager, JP (1998 b) Estimation of chlorzoxazone hydrolase activity in liver microsomes and of the plasma pharmacokinetics of chlorzoxazone by the same high-performance liquid-chromatographic method. Journal of Chromatography 4, 291–296.CrossRefGoogle Scholar
Lee, RG (1989) Nonalcoholic steatohepatitis: a study of 49 patients. Human Pathology 20, 594–598.CrossRefGoogle ScholarPubMed
Mortelmans, L, Nuyts, Y, Van Pamel, G, Van Den Magdenbergh, V, De Roo, M & Suetens, P (1986) A new thresholding method for volume determination by SPECT. European Journal of Nuclear Medicine 12, 284–290.CrossRefGoogle ScholarPubMed
Osawa, H & Mori, Y (1996) Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes. Journal of Clinical Ultrasound 24, 25–29.3.0.CO;2-N>CrossRefGoogle ScholarPubMed
O'Shea, D, Davis, SN, Kim, RB & Wilkinson, GR (1994) Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: A putative probe of CYP2E1 activity. Clinical Pharmacology and Therapeutics 56, 359–367.CrossRefGoogle ScholarPubMed
Ploeg, RJ, D'Alessandro, A, Knechtle, S, Stegall, MD, Pirsch, JD, Hoffmann, RM, Sasaki, T, Sollinger, HW, Belzer, FO & Kalayoglu, M (1993) Risk factors for primary dysfunction after liver transplantation — a multivariate analysis. Transplantation 55, 807–813.CrossRefGoogle ScholarPubMed
Raucy, JL, Lasker, JM, Lieber, C & Black, M (1989) Acetaminophen activation by human cytochromes P450IIE1 and P450IA2. Archives of Biochemistry and Biophysics 271, 270–283.CrossRefGoogle ScholarPubMed
Sheiner, LB (1983) ELSFIT (Version 3.0) A program for the extended least squares fit to individual pharmacokinetic data. San Francisco, CA: University of California.Google Scholar
Song, BJ, Veech, RL & Saenger, P (1990) Cytochrome P450IIE1 is elevated in lymphocytes from poorly controlled insulin-dependent diabetics. Journal of Clinical Endocrinology and Metabolism 71, 1036–1040.CrossRefGoogle ScholarPubMed
Tapner, M, Liddle, C, Goodwin, B, George, J & Farrell, GC (1996) Interferon gamma down-regulates cytochrome P450 3A genes in primary cultures of well-differentiated rat hepatocytes. Hepatology 24, 367–373.Google ScholarPubMed
Weltman, MD, Farrell, GC, Hall, P, Ingelman-Sundberg, M & Liddle, C (1998) Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 27, 128–133.CrossRefGoogle ScholarPubMed
Yun, YP, Casazza, JP, Sohn, DH, Veech, RL & Song, BJ (1991) Pretranslational activation of cytochrome P450IIE1 during ketosis induced by a high fat die. Molecular Pharmacology 41, 474–479.Google Scholar